MedPath
Found 3 clinical trials|View Analysis
Sort by:

Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

Phase 2
Recruiting
Conditions
Long COVID
Post Acute Sequelae of COVID-19
Post-Acute COVID-19
Interventions
Drug: Ensitrelvir
Other: Placebo
First Posted Date
2023-12-08
Last Posted Date
2024-06-04
Lead Sponsor
Timothy Henrich
Target Recruit Count
40
Registration Number
NCT06161688
Locations
🇺🇸

UCSF/Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

Phase 3
Recruiting
Conditions
COVID-19
Interventions
Drug: Shionogi Protease Inhibitor (S-217622)
Drug: placebo
First Posted Date
2022-11-04
Last Posted Date
2024-12-20
Lead Sponsor
University of Minnesota
Target Recruit Count
1500
Registration Number
NCT05605093
Locations
🇧🇷

Sociedade Literária e Caritativa Santo Agostinho - Hospital São José (Site 649-204), Criciuma, SC, Brazil

🇧🇷

Unimed Joinville Cooperativa de Trabalho Médico (Site 649-202), Joinville, SC, Brazil

🇺🇸

University of Alabama Birmingham University Hospital (Site 213-002), Birmingham, Alabama, United States

and more 163 locations

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Phase 2
Recruiting
Conditions
COVID-19
Interventions
Drug: Nirmatrelvir/ritonavir (e.g. PAXLOVIDâ„¢)
Drug: Nitazoxanide
Drug: Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVIDâ„¢)
Drug: Hydroxychloroquine
Other: No treatment
Drug: Monoclonal antibodies
Drug: Fluoxetine
Drug: Molnupiravir
Drug: Sotrovimab
Drug: Ensitrelvir
Drug: Favipiravir
Drug: Ivermectin
Drug: Remdesivir
Drug: Atilotrelvir/ritonavir
Drug: Metformin
Drug: Nirmatrelvir/ritonavir
Drug: Nirmatrelvir
First Posted Date
2021-09-13
Last Posted Date
2024-10-28
Lead Sponsor
University of Oxford
Target Recruit Count
3800
Registration Number
NCT05041907
Locations
🇳🇵

Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, Nepal

🇧🇷

Universidade Federal de Minas Gerais, Minas Gerais, Brazil

🇱🇦

Laos-Oxford-Mahosot Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath